Ribbon Biolabs

Making The Impossible Possible

Employees
11–50
Business Model
B2B
Total Funding
$20.1M
Last Round
$20.1M Series AJan 2022
Rounds
2

About

Ribbon Bio is a Vienna-based synthetic biology company that produces MiroSynth™ DNA using proprietary algorithm-driven enzymatic synthesis technology. Its platform manufactures pristine, high-accuracy synthetic DNA molecules — both linear (up to 12 kb) and circular (up to 20 kb) — free of bacterial constraints, enabling next-generation mRNA, CAR-T, and gene therapy applications. Ribbon serves biopharma and synthetic biology partners worldwide.

Summary

Ribbon Biolabs is a Biotech company. It has raised $20.1M in total across 2 rounds, most recently a $20.1M Series A round in Jan 2022. Investors include Hadean Ventures, Lansdowne Partners and Helicase Venture.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJan 2022
$20.1M

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ribbon Biolabs on Indexed.vc
<a href="https://indexed.vc/companies/ribbon-biolabs"><img src="https://indexed.vc/api/badge/company/ribbon-biolabs" alt="Ribbon Biolabs on Indexed.vc" width="260" height="76" /></a>